valeant makes $5.7 billion hostile bid for cephalon
valeant pharmaceuticals international offered to buy cephalon for $5.7 billion in cash on tuesday, kicking off a hostile bid for its smaller competitor after weeks of discussions failed to produce a deal.
http://feeds.nytimes.com/click.phdo?i=0fa942e2733b529f2461923d17d1cd27
9705
30 Mar 2011 19:02:23
nyt
business